páginas de la 51 a la 53

Referencias

  1. Diccionario de la lengua española. XXI Ed. Madrid: Real Academia Española, 1992.
  2. National Diabetes Data Group. Classification and diagnosis of glucose intolerance of diabetes mellitus and other categories. Diabetes 1979; 28: 1039-57.
  3. World Health Organization. Diabetes mellitus, 1985. WHO Technical Report Series 727. Geneve: WHO, 1985.
  4. Carvonen M, Tuomilehto J. Libman I, LaPorte R. For the World Health Organization.DIAMOND Project Group. A review of recent epidemiological data on the worldwide incidence of type I (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 883-92.
  5. Bennett PH. Changing concepts of the epidemiology of insulin-dependent diabetes. Diabetes Care 1985; 8, Suppl. 1: 29-33.
  6. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986; 314: 1360-8.
  7. Yoon JW, Austin M, Onodera T, Notkins AL. Virus induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300: 1173-9.
  8. Champsaur H, Bottazzo G, Bertrams J, Assan R, Bach C. Virologic, immunological and genetic factors in insulin-dependent diabetes mellitus. J Pediatr 1982; 101: 398-400.
  9. Ward KP, Galloway WH, Auchterlonie IA. Lancet 1979; 1:497.
  10. Karam JH, Lewitt PA, Young CW. Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes 1980; 29: 971-8.
  11. Gerstein HC. Cow´s milk exposure and type I diabetes mellitus. Diabetes Care 1994; 17: 13-19.
  12. Karjalainen J, Martin JM, Knip M, Ilonen J, Robinson BH, Savilathi E, Akerblom H, Dosch HM. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 1992; 327: 302-7.
  13. Craighead JE, McLane MF. Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 1968; 162: 913-14.
  14. Irvine WJ. Immunological aspects of diabetes mellitus. A review. En: Irvine WJ, ed. Immunology of diabetes. Edinburgh: Teviot Scientific Publications 1980: 1-53.
  15. Atkinson MA. Mac Laren NK, Scharp DW, Lacey PE, Riley WJ. Auto-antibodies as predictors of insulin-dependent diabetes. Lancet 1990; 335: 1357-60.
  16. Dorman J, LaPorte R, Stone R, Trucco M. Worldwide differences in the incidence of type I diabetes are associated with aminoacid variation at position 57 of the HLA-DQ beta chain. Proc Natl Acad Sci USA 1990; 87: 7370-4.
  17. Atkinson MA, Maclaren NK. What causes diabetes? Sci Am 1990; 263: 42-9.
  18. Shah SC, Malone JI, Simpson NE. A randomized trial of intensive insulin therapy in newly diagnosed type I insulin-dependent diabetes mellitus. N Engl J Med 1989; 320: 550-4.
  19. Barnett AH, Eff C, Leslie RDG, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.
  20. Mackay P, Jacobsen J, Ravinovitch A. Spontaneous diabetes mellitus in the biobreeding/ Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells. J Clin Invest 1986; 77: 916-924.
  21. Dengboll B, Green A. Diabetes mellitus among first and second degree relatives of early onset. Ann Hum Genet 1978; 42: 25-47.
  22. Warram JH, Krolewski AI, Gottlieb MS, Kahn CR. Difference in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984; 311: 149-52.
  23. Muir A, Schatz DA, Maclaren NK. The pathogenesis, prediction and prevention of insulin-dependent diabetes mellitus. Endocrinol Metab Clin North Am 1992; 21: 199.
  24. Baekkeskov S, Aanstoot HJ, Christgau S. Identification of the 64 K antigen in insulin-dependent diabetes as the GABA synthesizing enzyme glutamic acid decarboxilase. Nature 1990; 347: 151-6.
  25. Bougneres PF, Landais P, Boisson C. Limited duration of remission of insulin dependency in children with recent overt type-I diabetes treated with low -dose cyclosporine. Diabetes 1990; 39: 1264-72.
  26. Eisenbarth GS, Bellgrau D. Autoimmunity. Sci Am 1994; May/June: 38-47.
  27. Chavarría BC. Aspectos metabólicos. En: Diabetes mellitus en el niño y en el adolescente, 2a. edición. México: Ed. Francisco Méndez Oteo, 1978: 18-28.
  28. Kappy MS. Carbohydrate metabolism and hypoglycemia. En: Kappy MS, Blizzard LM, Migeon CJ, ed: The diagnosis and treatment of endocrine disorders in childhood and adolescence. Fourth ed. Sprinfield: Charles C. Thomas, 1994: 919-959.
  29. Davidson MB. Hypoglycemia in adults. En: Lavin N, ed. Manual of endocrinology and metabolism. New York: Little Brown Co, 1994: 459-76.
  30. Stetten DN, Mortimore GE. En: Williams RH, ed. Diabetes. Paul E. Hoeber, Inc. 1960: 89.
  31. Warren SH, Le Compte PHM, Legg MA. The pathology of diabetes mellitus. Philadelphia: Lea and Febiger, 1986.
  32. Weber B. Standardization of the oral glucose test. Internat Study Group Diabetes Child Adolesc Bulletin 1978; 2: 23-7.
  33. Brange J, Rivel U, Hansen JF. Monomeric insulins obtained by protein engineering and their medical implications. Nature 1988; 333: 679-82.
  34. Di Marchi RD, Mayer JP, Fan L. Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor 1. En: Smith HA, Rivier JE, ed. Peptides: che- mistry and biology. Proc. of the twelfth American Peptide Symposium. ESCOM, Leiden, Netherlands, 1992: 26-8.
  35. Howey DC, Browser RR, Brunelle RL, Woodworth JR. [Lys (B28), Pro (B29)]- Human insulin, a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396-402.
  36. Torlone E, Fanelli C, Rambotti AM. Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys (B28), Pro (B29)] in IDDM. Diabetologia 1994; 37: 713-20.
  37. Kang S, Owens DR, Vora JP, Brange J. Comparison of insulin analogue B9 Asp B27 Glu and soluble regular insulin in insulin-treated diabetes. Lancet 1990; 335: 303-6.
  38. Kang S, Creagh FM, Peters JR, Brange J, Volund A, Owens DR. Comparison of subcutaneous soluble regular insulin and insulin analogues (AspB9, GluB27, AspB10,AspB28) on meal related plasma glucose excursions in type I diabetic sujects. Diabetes Care 1991; 14: 571-7.
  39. ter Braak EWMT, Bianchi R, Erkelens DW. More suitable action profile for premeal treatment of Lys (B28) Pro (B29) insulin analogue than regular insulin. Diabetologia 36 (Suppl 1): A30 (Abstract) 1993.
  40. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression on long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
  41. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment on the development and progression of long-term complications in insulin dependent adolescents with diabetes mellitus. J Pediatr 1994; 125:177.
  42. American Diabetes Association. Nutritional recommendations and principles for individuals with diabetes mellitus. Diabetes Care 1987; 10: 126-32.
  43. Brink SJ. Pediatric, adolescent, and young-adult nutrition issues in IDDM. Diabetes Care 1988; 11: 192-200.
  44. Nutrition Subcommitee of the British Diabetes Association's Professional Advisory Committee. Dietary recommendations for people with diabetes: an update for the 1990´s. J Hum Nutr Dietetics 1991; 4: 393-412.
  45. National Research Council, National Academy of Sciences. Recommended Dietary Allowances. 10th ed. Washington, DC: National Academy Press, 1989.
  46. Horton ES. Role and management of exercise in diabetes mellitus. Diabetes Care 1988; 1: 201-11.
  47. Wahren J, Felig P, Hagenfeldt L. Physical exercise and fuel homeostasis in diabetes mellitus. Diabetologia 1978; 14: 213-22.
  48. Frid A, Ostman J, Linde B. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care 1990; 13: 473-7.
  49. Sherwin RS, Koivisto V. Keeping in step: does exercise benefit the diabetic? Diabetologia 1981; 20: 84-6.
  50. The DCCT Research Group. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 1991; 90: 450-9.
  51. Macfarlane PI, Walters M, Stutchfield P, Smith CS. A prospective study of symptomatic hypoglycemia in childhood diabetes. Diabetic Med 1989; 6: 627-30.
  52. Davis MR, Mellman M, Shamoon H. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM. Diabetes 1992; 41: 1335-40.
  53. Porter PA, Keating B, Byrne G, Jones TW. Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus. J Pediatr 1997; 130: 366-71.
  54. Sperling MA. The Scylla and Charybdis of blood glucose control in children with diabetes mellitus. J Pediatr 1997; 130: 339-41.
  55. Jones TW, MaCarthy WV, Tamborlane S. Mild hypoglycemia and impairment of brainstem and cortical evoked potentials in healthy subjects. Diabetes 1990; 39: 1550-4.
  56. Wolsdorf JI, Anderson BJ, Pasquarello C. Treatment of the child with diabetes. En: Kahn CR, Weir GC, ed. Joslin´s diabetes mellitus. 13th ed. Philadelphia: Lea and Febiger, 1994: 530-51.
  57. Blanco LA, Salgado CM. Cetoacidosis diabética. En: Rodríguez SR, Velásquez JL, Valencia MP, Nieto ZJ, Serrano SA, ed. Urgencias en pediatría. 4a. ed. México: Interamericana McGraw-Hill, 1996: 439-44.
  58. Blanco LA. Cetoacidosis diabética. En. Velásquez JL, ed. Alteraciones hidroelectrolíticas en pediatría. México: Ediciones Médicas del Hospital Infantil de México, 1991: 230-6.
  59. Unger RH, Foster DW. Diabetes mellitus. En: Wilson JD, Foster EW, ed. Williams texbook of Endocrinology. 8a. ed. Philadelphia: WB Saunders. Co., 1992: 1255-1331.
  60. Sahfir E, Bergman M, Felig P. Diabetes. En: Felig P, Baxter JD, Broadus AE, Frohman LA, ed. Endocrinology and metabolism. 2nd. ed. New York: MacGraw-Hill Book Co., 1987: 1043-1178.
  61. Narins RG, Kopit NP, Kleeman CHR. Diabetic acidosis and coma. En: Maxwell MH, Kleeman CHR, Narins RG, ed. Clinical disorders of electrolyte metabolism. 4th ed. New York: McGraw-Hill Book Co., 1987: 643-74.
  62. Unger RH. Role of glucagon in the pathogenesis of diabetes: the status of the controversy. Metabolism 1978; 27: 1691-1709.
  63. Foster DW, McGarry JD. Acute complications of diabetes: ketoacidosis, hyperosmolar coma, lactic acidosis. En: De Groot L, Besser GM, Cahill GF, ed. Endocrinology. 2nd. ed. Philadelphia: WB Saunders Co., 1989: 1439-53.
  64. Felig P. Insulin, glucagon and somatostatin in normal physiology and diabetes mellitus. Diabetes 1976; 25: 1091-99.
  65. Alberti KGMM, Hockaday TDR. Diabetic coma: a reappraisal after five years. J Clin Endocrinol Metab 1977; 6: 421-55.
  66. Hochaday TDR, Alberti KGMM. Diabetic coma. J Clin Endocrinol Metab 1972; 1: 751-88.
  67. Butler AM. Parenteral fluid therapy in diabetic coma. Acta Paediatr Scand 1949; 38: 59-70.
  68. Golfarb S. Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms. Ann Intern Med 1976; 84: 426-32.
  69. Chieslieb AR. Plasma renin activity and blood volume in uncontrolled diabetes. Ketoacidosis, state of secondary aldosteronism. Diabetes 1975; 24: 190-3.
  70. Kern EF, Simmons DA, Martin DB. Diabetic ketoacidosis and hyperglycemic nonketonic coma. En: Geelhoed GW, Chernow B, ed. Endocrine aspects of acute illness. New York: Churchill Livingstone Inc., 1985: 285-305.
  71. Hers HG, Van Schaftingen E. Fructose 1,6 biphosphate two years after its discovery. Biochem J 1982; 206: 1-12.
  72. Richards CS, Uyeda K. Changes in the concentration of activation factor for phosphofructokinase in hepatocytes in response to glucose and glucagon. Biochem Biophys Res Commun 1980; 97: 1535-40.
  73. Richard CS, Uyeda K. Hormonal regulation of fructose-6-P,2 kinase and fructose-2, 6-P2 by two mechanisms. J Biol Chem 1982; 257: 8854-61.
  74. Mouritz-Andersen T, Jensen IW, Nielsen LK, Nielsen GL, Dyerberg J, Dietzel J. Plasma 6-keto-PGF1 Alpha, Tromboxane B2 and PGE2 during diabetic ketoacidosis. Prostaglandins Leukotrienes and Essential Fatty Acids 1990; 40 : 39-43.
  75. McGarry JD, Leatherman GF. Carnitine palmitoyl transferase. I. The site of inhibition of hepatic fatty oxidation by malonil-CoA. J Biol Chem 1978; 253: 4128-36.
  76. Salgado CM, Blanco LA. Recursos logísticos ante la diabetes mellitus. Acta Pediat Mex 1995; 16: 201-7.
  77. Sulway MJ, Malins JM. Acetone in diabetic ketoacidosis. Lancet 1970; 2: 736-40.
  78. Emmett M, Narins RG. Clinical use of the anion gap. Medicine 1977; 56: 38-54.
  79. Blanco-López A, Elizundia-Charles F, Rodríguez M, Salgado-Cabrera M, López-Lizano C, Lorenzo Negrete MA, Limón-Arce R. Cetoacidosis diabética. Pediatría Rural y Extra-hospitalaria 1994; 24: 288-98.
  80. Blanco-López A. Elizundia-Charles F, López-Lizano C, Serrano-SierraA, Salgado-Cabrera M, Ocampo-Lujano R. Cetoacidosis dia- bética. Bol Med Hosp Infant Mex 1993; 50: 64-9.
  81. Hanley RM. Diabetic emergencies. They happen with or without diabetes. Postgraduate Medicine 1990; 883: 90-6.
  82. Harris GD, Fiordalisi IM, Harris WL, Masovich LL, Fingerg L. Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: A retrospective and prospective study. J Pediatr 1991; 121: 106-17.
  83. Kaufman IA. Diabetic ketoacidosis and acidosis: the continous infussion of low doses of insulin. J Pediatr 1975; 87: 846-48.
  84. Velásquez JL. Alteraciones hidroelectrolíticas y ácido-base. II. Hipokalemia. Bol Med Hosp Infant Méx 1988; 45: 478-81.
  85. Riley LJ Jr, Cooper M, Narins RG. Alkali therapy of diabetic ketoacidosis: Biochemical, physiologic and clinical perspectives. Diabetes-Metabolism Reviews 1989; 58: 627-36.
  86. Chang TC, Jap TS, Kwok CF, Won JG, Ho LT. Intractable diabetic ketoacidosis due to insulin antibody response to steroid therapy. Chinese Medical Journal 1990; 45: 83-6.